tiprankstipranks
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
PremiumPress ReleasesAmicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
2M ago
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
PremiumPress Releases
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
3M ago
Amicus’ (NASDAQ:FOLD) 2023 Sales Exceed Expectations
PremiumMarket News
Amicus’ (NASDAQ:FOLD) 2023 Sales Exceed Expectations
4M ago
Amicus executive chairman John Crowley to step down
PremiumThe FlyAmicus executive chairman John Crowley to step down
5M ago
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
PremiumPress Releases
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
5M ago
Amicus files to sell 2.47M shares of common stock for holders
PremiumThe Fly
Amicus files to sell 2.47M shares of common stock for holders
6M ago
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
PremiumPress ReleasesAmicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
‘Stay Invested Through the Uncertainty’: J.P. Morgan Says Stocks Could Reach New Highs Next Year — Here Are 2 Names to Pounce on Now
PremiumStock Analysis & Ideas
‘Stay Invested Through the Uncertainty’: J.P. Morgan Says Stocks Could Reach New Highs Next Year — Here Are 2 Names to Pounce on Now
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100